Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IMP4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | ZCCHC7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | DLX5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | ERRFI1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | SOX1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | GIMAP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | NT5M | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | PRSS53 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | GPR75-ASB3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | TTC39C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |